메뉴 건너뛰기
소속 기관 / 학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
고객센터 ENG
주제분류

논문 기본 정보

저자정보
출처
Wiley Microbial Biotechnology 18(10)
오류 신고하기
표지

검색

    초록·키워드

    The global rise of drug-resistant bacterial infections underscores an urgent demand for novel antimicrobial agents. Roseoflavin, a naturally occurring riboflavin analog, has emerged as a promising candidate for drug development. In this study, the industrial workhorse Corynebacterium glutamicum was metabolically engineered towards roseoflavin production. Overexpression of the roseoflavin biosynthetic genes rosABC and the flavin transport gene ribM from the native roseoflavin producer Streptomyces davaonensis was evaluated in C. glutamicum. To further link roseoflavin biosynthesis to its riboflavin precursor, the riboflavin kinase gene ribF from both S. davaonensis and C. glutamicum was evaluated, revealing that its overexpression is essential for enhancing roseoflavin production. The final engineered strain CgRose6 achieved a roseoflavin titer of 17.4 ± 1.5 mg/L and a volumetric productivity of 0.36 ± 0.03 mg/L·h when cultivated in glucose minimal medium supplemented with thiamine, a relevant coenzyme for roseoflavin biosynthesis. These production values are the highest reported by a non-native RoF producer to date and demonstrate the feasibility of using C. glutamicum as a platform for sustainable roseoflavin production, opening avenues for scalable biosynthesis of this valuable antimicrobial compound.

    본문·목차

    최근 본 자료 전체보기